RSVP - Flu Like Illness and Respiratory Syndromes COVID-19 Syndromic Reporting Tool Prototype
- Sandia National Laboratories (SNL), Albuquerque, NM, and Livermore, CA (United States)
Individuals infected with SARS-CoV-2, the virus that causes COVID-19, may be infectious between 1-3 days prior to symptom onset. People may delay seeking medical care after symptom development due to multiple determinants of health seeking behavior like availability of testing, accessibility of providers, and ability to pay. Therefore, understanding symptoms in the general public is important to better predict and inform resource management plans and engage in reopening. As the influenza season looms, the ability to differentiate between clinical presentation of COVID-19 and seasonal influenza will also be important to health providers and public health response efforts. This project has developed an algorithm that when used with captured syndromic trends can help provide both differentiation to various influenza-like illnesses (ILI) as well as provide public health decision makers a better understanding regarding spatial and temporal trends. This effort has also developed a web-based tool to allow for the capturing of generalized syndromic trends and provide both spatial and temporal outputs on these trends. This page left blank
- Research Organization:
- Sandia National Laboratories (SNL-NM), Albuquerque, NM (United States)
- Sponsoring Organization:
- USDOE National Nuclear Security Administration (NNSA)
- DOE Contract Number:
- AC04-94AL85000; NA0003525
- OSTI ID:
- 1662018
- Report Number(s):
- SAND--2020-9353; 690549
- Country of Publication:
- United States
- Language:
- English
Similar Records
Rapid Syndrome Validation Project (RSVP)